Follow Us

Pfizer Stock Price Has Potential to Reach $75, Suggests Analysts

Share on facebook
Share on twitter
Share on linkedin

Share

Pfizer Stock Price Has Potential to Reach $75, Suggests Analysts
Share on facebook
Share on twitter
Share on linkedin

Pfizer Inc. (PFE) stock price slumped nearly 6.75% in the last week. The PFE stock trades in the bearish territory. The stock is struggling to get the buyers’ participation near the previous swing low and is consolidated. 

The daily chart illustrates that the Pfizer stock price showed a breakdown from a 2-year low and slid to a lower level of $33.44. The price-chart study of the past 6 months shows that the PFE stock price closely followed the 50-day EMA and rolled down.

The Pfizer stock needs buying volume to counter the declining momentum and shift the trend. However, it will not be that easy for the buyers to make a trend change as there are several resistances on the upper side. 

The analysts offering a 1-year price forecast for Pfizer Inc. have a wide range of possibilities with an upside potential of 120% in the stock which could lead the price to a high of $75. The analysts expect a drawdown of 5.85% which might drag the price to a low of $32.

 Source: barchart.com

Pfizer stock option-chain analysis states that the current implied volatility in the market is 21.04% with an increment of 0.56% in the last trading session. The at-the-money strike has an OI of 6,203 on the PUT side and 8,503 on the CALL side indicating the sellers dominating at the CMP. 

Pfizer Stock Price Made Breakdown of a Bearish Flag 

Source: Pfizer, Inc.  1D. NYSE By TradingView

The PFE stock price currently trades at $33.99 and consolidated near the low after forming a new low. Bulls are trying to halt the declining momentum and turn the trend in their favor. 

The breakdown of the consolidation may trigger another selling and the PFE price may drop to the lower levels. The sellers are in dominance and it would be easy for sellers to resume with the trend. The option chain data favors the dominance of sellers at CMP. 

Technical Indicators Show Sideways to Bearish Trend 

Source: Pfizer, Inc.  1D. NYSE By TradingView

The daily PFE stock price chart shows that the price has declined below the 50-day EMA; indicating short-selling from the upper levels. 

The overall technical opinion rating includes RSI and MACD signals a 90% “sell” with the average short-term outlook on maintaining the current direction.

Conclusion

Pfizer Inc. is a company that makes and sells pharmaceutical products. The PFE stock price has fallen by 6.75% in the last week and is trading in a bearish trend. The price broke below a 2-year low and is consolidating near the bottom. The price needs more buying volume to change the trend but faces a lot of resistance on the upper side. The analysts have a wide range of predictions for the next year with a high of $75 and a low of $32. The option data shows that the sellers are dominating at the current price.

Technical Levels

  • Support levels: $33.38 and $32.64
  • Resistance levels: $35.51 and $37.11
Disclaimer

The views and opinions stated by the author, or any people named in this article, are for informational purposes only and do not establish financial, investment, or other advice. Investing in or trading crypto or stock comes with a risk of financial loss.

Leave a Reply

Your email address will not be published. Required fields are marked *

Download our App for getting faster updates at your fingertips.

en_badge_web_generic.b07819ff-300x116-1

We Recommend

Top Rated Cryptocurrency Exchange

-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00